Canada markets open in 6 hours 50 minutes

Biotest Aktiengesellschaft (0N6Z.L)

LSE - LSE Delayed Price. Currency in EUR
Add to watchlist
43.00+0.10 (+0.23%)
At close: 09:08AM BST
Currency in EUR

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.22
52-Week Change 3N/A
S&P500 52-Week Change 324.96%
52 Week High 30.00
52 Week Low 30.00
50-Day Moving Average 3N/A
200-Day Moving Average 3N/A

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 539.57M
Implied Shares Outstanding 6N/A
Float 820.5M
% Held by Insiders 197.14%
% Held by Institutions 10.21%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.04
Trailing Annual Dividend Yield 30.09%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 22.60%
Operating Margin (ttm)24.54%

Management Effectiveness

Return on Assets (ttm)8.47%
Return on Equity (ttm)40.25%

Income Statement

Revenue (ttm)782.6M
Revenue Per Share (ttm)19.61
Quarterly Revenue Growth (yoy)83.60%
Gross Profit (ttm)N/A
EBITDA 208.95M
Net Income Avi to Common (ttm)176.9M
Diluted EPS (ttm)-1.37
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)84.7M
Total Cash Per Share (mrq)2.12
Total Debt (mrq)693.2M
Total Debt/Equity (mrq)131.31%
Current Ratio (mrq)2.04
Book Value Per Share (mrq)13.24

Cash Flow Statement

Operating Cash Flow (ttm)23M
Levered Free Cash Flow (ttm)-60.54M